trending Market Intelligence /marketintelligence/en/news-insights/trending/TdE5CvKKHo9ksskhty2QYQ2 content esgSubNav
In This List

Summit Therapeutics CFO to resign

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Summit Therapeutics CFO to resign

Summit Therapeutics PLC said Erik Ostrowski would step down as CFO at the end of December.

"The company will appoint a new chief financial officer in due course," Summit Therapeutics said.

Abingdon, U.K.-based Summit Therapeutics is a biopharmaceutical company that focuses on the discovery, development and commercialization of novel medicines to treat rare and infectious diseases.